Functional MRI signal changes in primary visual cortex corresponding to the central normal visual field of patients with primary open-angle glaucoma

Investigative Ophthalmology and Visual Science

Volumn 51, Issue 9, 2010, Pages 4627-4634

  Qing, Guoping ^a   Zhang, Shaodan ^a   Wang, Bo ^b   Wang, Ningli ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b INSTITUTE OF BIOPHYSICS   (China)

Author keywords

[No Author keywords available]

Indexed keywords

OXYGEN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DISEASE SEVERITY; EYE FUNDUS; EYE REFRACTION; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GONIOSCOPY; HUMAN; INTRAOCULAR PRESSURE; MALE; NERVE CELL; NEUROPATHY; OPEN ANGLE GLAUCOMA; OXYGEN BLOOD LEVEL; PERIMETRY; PRESSURE MEASUREMENT; PRIORITY JOURNAL; SCANNING LASER OPHTHALMOSCOPY; VISUAL ACUITY; VISUAL CORTEX; VISUAL FIELD DEFECT; VISUAL STIMULATION; BLOOD; METHODOLOGY; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTICAL COHERENCE TOMOGRAPHY; PATHOLOGY; PATHOPHYSIOLOGY; PHOTOSTIMULATION; PHYSIOLOGY; RETINA; VISUAL FIELD; VISUAL SYSTEM;

FEMALE; GLAUCOMA, OPEN-ANGLE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OXYGEN; PHOTIC STIMULATION; RETINA; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL CORTEX; VISUAL FIELDS; VISUAL PATHWAYS;

EID: 77957358103     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.09-4834     Document Type: Article

References (66)

1. Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006;90:262-267.
2. Werner EB, Beraskow J. Peripheral nasal field defects in glaucoma. Ophthalmology. 1979;86:1875-1878.
3. Werner EB, Drance SM. Early visual field disturbances in glaucoma. Arch Ophthalmol. 1977;95:1173-1175.
4. Harwerth RS, Smith EL 3rd, DeSantis L. Behavioral perimetry in monkeys. Invest Ophthalmol Vis Sci. 1993;34:31-40.
5. Much JW, Liu C, Piltz-Seymour JR. Long-term survival of central visual field in end-stage glaucoma. Ophthalmology. 2008;115: 1162-1166.
6. Ansari EA, Morgan JE, Snowden RJ. Psychophysical characterization of early functional loss in glaucoma and ocular hypertension. Br J Ophthalmol. 2002;86:1131-1135.
7. McKean-Cowdin R, Wang Y, Wu J, Azen SP, Varma R. Impact of visual field loss on health-related quality of life in glaucoma: the Los Angeles Latino Eye Study. Ophthalmology. 2008;115:941-948+941.
8. McKendrick AM, Badcock DR, Morgan WH. Psychophysical measurement of neural adaptation abnormalities in magnocellular and parvocellular pathways in glaucoma. Invest Ophthalmol Vis Sci. 2004;45:1846-1853.
9. McKendrick AM, Badcock DR, Morgan WH. The detection of both global motion and global form is disrupted in glaucoma. Invest Ophthalmol Vis Sci. 2005;46:3693-3701.
10. Sampson GP, Badcock DR, Walland MJ, McKendrick AM. Foveal contrast processing of increment and decrement targets is equivalently reduced in glaucoma. Br J Ophthalmol. 2008;92:1287-1292.
11. Stamper RL. The effect of glaucoma on central visual function. Trans Am Ophthalmol Soc. 1984;82:792-826.
12. Yucel YH, Zhang Q, Weinreb RN, Kaufman PL, Gupta N. Effects of retinal ganglion cell loss on magno-, parvo-, koniocellular pathways in the lateral geniculate nucleus and visual cortex in glaucoma. Prog Retin Eye Res. 2003;22:465-481.
13. Gupta N, Yucel YH. Glaucoma and the brain. J Glaucoma. 2001; 10:S28-S29.
14. Graham SL, Klistorner AI, Goldberg I. Clinical application of objective perimetry using multifocal visual evoked potentials in glaucoma practice. Arch Ophthalmol. 2005;123:729-739.
15. Graham SL, Klistorner AI, Grigg JR, Billson FA. Objective VEP perimetry in glaucoma: asymmetry analysis to identify early deficits. J Glaucoma. 2000;9:10-19.
16. Hood DC, Thienprasiddhi P, Greenstein VC, et al. Detecting early to mild glaucomatous damage: a comparison of the multifocal VEP and automated perimetry. Invest Ophthalmol Vis Sci. 2004;45: 492-498.
17. Parisi V, Miglior S, Manni G, Centofanti M, Bucci MG. Clinical ability of pattern electroretinograms and visual evoked potentials in detecting visual dysfunction in ocular hypertension and glaucoma. Ophthalmology. 2006;113:216-228.
18. Thienprasiddhi P, Greenstein VC, Chen CS, Liebmann JM, Ritch R, Hood DC. Multifocal visual evoked potential responses in glaucoma patients with unilateral hemifield defects. Am J Ophthalmol. 2003;136:34-40.
19. Thienprasiddhi P, Greenstein VC, Chu DH, et al. Detecting early functional damage in glaucoma suspect and ocular hypertensive patients with the multifocal VEP technique. J Glaucoma. 2006;15: 321-327.
20. Kiyosawa M, Bosley TM, Kushner M, et al. Positron emission tomography to study the effect of eye closure and optic nerve damage on human cerebral glucose metabolism. Am J Ophthalmol. 1989;108:147-152.
21. Sugiyama T, Utsunomiya K, Ota H, Ogura Y, Narabayashi I, Ikeda T. Comparative study of cerebral blood flow in patients with normal-tension glaucoma and control subjects. Am J Ophthalmol. 2006;141:394-396.
22. Howseman AM, Bowtell RW. Functional magnetic resonance imaging: imaging techniques and contrast mechanisms. Phil Trans R Soc Lond B Biol Sci. 1999;354:1179-1194.
23. Turner R, Howseman A, Rees GE, Josephs O, Friston K. Functional magnetic resonance imaging of the human brain: data acquisition and analysis. Exp Brain Res. 1998;123:5-12.
24. Duncan RO, Sample PA, Weinreb RN, Bowd C, Zangwill LM. Retinotopic organization of primary visual cortex in glaucoma: a method for comparing cortical function with damage to the optic disk. Invest Ophthalmol Vis Sci. 2007;48:733-744.
25. Sunness JS, Liu T, Yantis S. Retinotopic mapping of the visual cortex using functional magnetic resonance imaging in a patient with central scotomas from atrophic macular degeneration. Ophthalmology. 2004;111:1595-1598.
26. Williams MA, Morris AP, McGlone F, Abbott DF, Mattingley JB. Amygdala responses to fearful and happy facial expressions under conditions of binocular suppression. J Neurosci. 2004;24:2898-2904.
27. Kerrigan-Baumrind LA, Quigley HA, Pease ME, Kerrigan DF, Mitchell RS. Number of ganglion cells in glaucoma eyes compared with threshold visual field tests in the same persons. Invest Ophthalmol Vis Sci. 2000;41:741-748.
28. Desatnik H, Quigley HA, Glovinsky Y. Study of central retinal ganglion cell loss in experimental glaucoma in monkey eyes. J Glaucoma. 1996;5:46-53.
29. Harwerth RS, Quigley HA. Visual field defects and retinal ganglion cell losses in patients with glaucoma. Arch Ophthalmol. 2006;124: 853-859.
30. Crawford ML, Harwerth RS, Smith EL 3rd, Shen F, Carter-Dawson L. Glaucoma in primates: cytochrome oxidase reactivity in parvoand magnocellular pathways. Invest Ophthalmol Vis Sci. 2000;41: 1791-1802.
31. Crawford ML, Harwerth RS, Smith EL 3rd, Mills S, Ewing B. Experimental glaucoma in primates: changes in cytochrome oxidase blobs in V1 cortex. Invest Ophthalmol Vis Sci. 2001;42:358-364.
32. Chen E, Gedda U, Landau I. Thinning of the papillomacular bundle in the glaucomatous eye and its influence on the reference plane of the Heidelberg retinal tomography. J Glaucoma. 2001;10:386-389.
33. Guedes V, Schuman JS, Hertzmark E, et al. Optical coherence tomography measurement of macular and nerve fiber layer thickness in normal and glaucomatous human eyes. Ophthalmology. 2003;110:177-189.
34. Zeimer R, Asrani S, Zou S, Quigley H, Jampel H. Quantitative detection of glaucomatous damage at the posterior pole by retinal thickness mapping: a pilot study. Ophthalmology. 1998;105:224-231.
35. Harwerth RS, Carter-Dawson L, Shen F, Smith EL 3rd, Crawford ML. Ganglion cell losses underlying visual field defects from experimental glaucoma. Invest Ophthalmol Vis Sci. 1999;40:2242-2250.
36. Klistorner AI, Graham SL. Early magnocellular loss in glaucoma demonstrated using the pseudorandomly stimulated flash visual evoked potential. J Glaucoma. 1999;8:140-148.
37. Quigley HA, Sanchez RM, Dunkelberger GR, L'Hernault NL, Baginski TA. Chronic glaucoma selectively damages large optic nerve fibers. Invest Ophthalmol Vis Sci. 1987;28:913-920.
38. Glovinsky Y, Quigley HA, Dunkelberger GR. Retinal ganglion cell loss is size dependent in experimental glaucoma. Invest Ophthalmol Vis Sci. 1991;32:484-491.
39. King WM, Sarup V, Sauve Y, Moreland CM, Carpenter DO, Sharma SC. Expansion of visual receptive fields in experimental glaucoma. Vis Neurosci. 2006;23:137-142.
40. Sharma SC. Changes of central visual receptive fields in experimental glaucoma. Prog Brain Res. 2008;173:479-491.
41. Gupta N, Ly T, Zhang Q, Kaufman PL, Weinreb RN, Yucel YH. Chronic ocular hypertension induces dendrite pathology in the lateral geniculate nucleus of the brain. Exp Eye Res. 2007;84:176-184.
42. Gupta N, Yucel YH. Brain changes in glaucoma. Eur J Ophthalmol. 2003;13(suppl 3):S32-S35.
43. Lam DY, Kaufman PL, Gabelt BT, To EC, Matsubara JA. Neurochemical correlates of cortical plasticity after unilateral elevated intraocular pressure in a primate model of glaucoma. Invest Ophthalmol Vis Sci. 2003;44:2573-2581.
44. Eysel UT, Wolfhard U. The effects of partial retinal lesions on activity and size of cells in the dorsal lateral geniculate nucleus. J Comp Neurol. 1984;229:301-309.
45. Reinhard JF Jr, Liebmann JE, Schlosberg AJ, Moskowitz MA. Serotonin neurons project to small blood vessels in the brain. Science. 1979;206:85-87.
46. Vaucher E, Hamel E. Cholinergic basal forebrain neurons project to cortical microvessels in the rat: electron microscopic study withanterogradely transported Phaseolus vulgaris leucoagglutinin and choline acetyltransferase immunocytochemistry. J Neurosci. 1995; 15:7427-7441.
47. Yang G, Huard JM, Beitz AJ, Ross ME, Iadecola C. Stellate neurons mediate functional hyperemia in the cerebellar molecular layer. J Neurosci. 2000;20:6968-6973.
48. Gupta N, Ang LC, Noel de Tilly L, Bidaisee L, Yucel YH. Human glaucoma and neural degeneration in intracranial optic nerve, lateral geniculate nucleus, and visual cortex. Br J Ophthalmol. 2006;90:674-678.
49. Gupta N, Greenberg G, de Tilly LN, Gray B, Polemidiotis M, Yucel YH. Atrophy of the lateral geniculate nucleus in human glaucoma detected by magnetic resonance imaging. Br J Ophthalmol. 2009; 93:56-60.
50. Ito Y, Shimazawa M, Chen YN, et al. Morphological changes in the visual pathway induced by experimental glaucoma in Japanese monkeys. Exp Eye Res. 2009;89:246-255.
51. Sasaoka M, Nakamura K, Shimazawa M, Ito Y, Araie M, Hara H. Changes in visual fields and lateral geniculate nucleus in monkey laser-induced high intraocular pressure model. Exp Eye Res. 2008; 86:770-782.
52. Wang X, Sam-Wah Tay S, Ng YK. Nitric oxide, microglial activities and neuronal cell death in the lateral geniculate nucleus of glaucomatous rats. Brain Res. 2000;878:136-147.
53. Weber AJ, Chen H, Hubbard WC, Kaufman PL. Experimental glaucoma and cell size, density, and number in the primate lateral geniculate nucleus. Invest Ophthalmol Vis Sci. 2000;41:1370-1379.
54. Yucel YH, Zhang Q, Gupta N, Kaufman PL, Weinreb RN. Loss of neurons in magnocellular and parvocellular layers of the lateral geniculate nucleus in glaucoma. Arch Ophthalmol. 2000;118:378-384.
55. Yucel YH, Zhang Q, Weinreb RN, Kaufman PL, Gupta N. Atrophy of relay neurons in magno- and parvocellular layers in the lateral geniculate nucleus in experimental glaucoma. Invest Ophthalmol Vis Sci. 2001;42:3216-3222.
56. Gordon GR, Mulligan SJ, MacVicar BA. Astrocyte control of the cerebrovasculature. Glia. 2007;55:1214-1221.
57. Metea MR, Newman EA. Glial cells dilate and constrict bloodvessels: a mechanism of neurovascular coupling. J Neurosci. 2006; 26:2862-2870.
58. Alkayed NJ, Birks EK, Narayanan J, Petrie KA, Kohler-Cabot AE, Harder DR. Role of P-450 arachidonic acid epoxygenase in the response of cerebral blood flow to glutamate in rats. Stroke. 1997;28:1066-1072.
59. Blanco VM, Stern JE, Filosa JA. Tone-dependent vascular responsesto astrocyte-derived signals. Am J Physiol. 2008;294:H2855-H2863.
60. Zonta M, Angulo MC, Gobbo S, et al. Neuron-to-astrocyte signaling is central to the dynamic control of brain microcirculation. Nat Neurosci. 2003;6:43-50.
61. Ong K, Farinelli A, Billson F, Houang M, Stern M. Comparative study of brain magnetic resonance imaging findings in patients with low-tension glaucoma and control subjects. Ophthalmology. 1995;102:1632-1638.
62. Stroman GA, Stewart WC, Golnik KC, Cure JK, Olinger RE. Magnetic resonance imaging in patients with low-tension glaucoma. Arch Ophthalmol. 1995;113:168-172.
63. Harris A, Zarfati D, Zalish M, et al. Reduced cerebrovascular blood flow velocities and vasoreactivity in open-angle glaucoma. Am J Ophthalmol. 2003;135:144-147.
64. Harris A, Siesky B, Zarfati D, et al. Relationship of cerebral blood flow and central visual function in primary open-angle glaucoma. J Glaucoma. 2007;16:159-163.
65. Sheth SA, Nemoto M, Guiou M, et al. Columnar specificity of microvascular oxygenation and volume responses: implications for functional brain mapping. J Neurosci. 2004;24:634-641.
66. Duong TQ, Kim DS, Ugurbil K, Kim SG. Localized cerebral blood flow response at submillimeter columnar resolution. Proc NatlAcad Sci U S A. 2001;98:10904-10909.